From the annual report they are burning cash trying to operate these machines with employees being the biggest expense which I doubt will be cut and I suspect will grow as they deploy more machines. The other costs of travel marketing legal etc are not big hitters and I don’t see how they can be cut or if they are they won’t make a big difference. I have had a quick look through these posts and releases - has anyone seen their path to profitable operations. Has it been articulated anywhere? Selling more unprofitable machines just puts their valuation closer to the cash they hold if they don’t have a clear path to profitability in my opinion. They look like a gold miner sitting on a heap of deep high grade refractory gold in the middle of nowhere at the moment. I love their tech and the story but am reluctant to drink the cool aid until I can see the inflection to profitability.
- Forums
- ASX - By Stock
- C79
- Ann: Chrysos FY22 Results announcement
Ann: Chrysos FY22 Results announcement, page-9
Featured News
Add C79 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.21 |
Change
0.150(2.96%) |
Mkt cap ! $586.1M |
Open | High | Low | Value | Volume |
$5.02 | $5.22 | $5.02 | $98.65K | 19.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 259 | $5.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.23 | 463 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 259 | 5.180 |
3 | 8 | 5.170 |
2 | 278 | 5.160 |
3 | 1889 | 5.150 |
1 | 116 | 5.140 |
Price($) | Vol. | No. |
---|---|---|
5.230 | 463 | 2 |
5.240 | 1056 | 2 |
5.250 | 241 | 1 |
5.280 | 997 | 2 |
5.320 | 756 | 1 |
Last trade - 13.27pm 18/11/2024 (20 minute delay) ? |
Featured News
C79 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online